US Insulin Delivery Devices: Patient Acceptance Drives Demand

US Insulin Delivery Devices: Patient Acceptance Drives Demand

Summary

GlobalData’s “US Insulin Delivery Devices Market: Patient Acceptance Drives Demand” report is an essential source of data and analysis on the US insulin delivery devices market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on four market categories – insulin jet injectors, insulin pens, insulin pumps and insulin syringes. The report identifies the key trends shaping and driving the dynamism in the US insulin delivery devices market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the US insulin delivery devices market.

Scope

- The report provides market size data and information on four US insulin delivery devices market categories – Insulin Jet Injectors, Insulin Pens, Insulin Pumps and Insulin Syringes.
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
- Analysis and review of the key events and milestones that will impact the future of the US insulin delivery devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the US insulin delivery devices market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- Key topics covered include the M&A landscape and the impact of the economic downturn on the US insulin delivery devices market.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the US insulin delivery devices Market.
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the US insulin delivery devices market in future.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- What’s the next being thing in the US insulin delivery devices technology landscape? – Identify, understand and capitalize.

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Executive Summary 6
3 Definitions 7
3.1 Insulin Delivery 7
3.1.1 Insulin Jet Injectors 7
3.1.2 Insulin Pens 7
3.1.3 Insulin Pumps 7
3.1.4 Insulin Syringes 7
4 US Insulin Delivery Devices: Patient Acceptance Drives Demand 8
4.1 Overview 8
4.2 Opportunities in the US Insulin Delivery Devices Market 9
4.3 Insulin Pens and Insulin Pumps: Driving Growth in the US Insulin Delivery Devices Market 11
4.4 Insulin Delivery Devices: Market Drivers 13
4.5 Insulin Delivery Devices: Market Restraints 14
4.6 Economic Recession in the US: Impact on the Insulin Delivery Devices Market 14
5 Insulin Delivery Devices: Pipeline Products 15
5.1 AERx insulin Diabetes Management System (AERx iDMS) 15
5.2 Insulin Nanopump 16
5.3 SOLO SYSTEM 16
6 Insulin Delivery Devices: Competitive Landscape 17
7 Insulin Jet Injectors 19
7.1 Insulin Jet Injectors Market Size, US, Historic, 2001 – 2008 19
7.2 Insulin Jet Injectors Market Size, US, Forecast, 2008 – 2015 20
8 Insulin Pens 22
8.1 Insulin Pens Market Size, US, Historic, 2001 – 2008 22
8.2 Insulin Pens Market Size, US, Forecast, 2008 – 2015 23
9 Insulin Pumps 25
9.1 Insulin Pumps Market Size, US, Historic, 2001 – 2008 25
9.2 Insulin Pumps Market Size, US, Forecast, 2008 – 2015 27
9.3 Disposable Insulin Pumps: Insulet Corporation’s OmniPod 28
10 Insulin Syringes 30
10.1 Insulin Syringes Market Size, US, Historic, 2001 – 2008 30
10.2 Insulin Syringes Market Size, US, Forecast, 2008 – 2015 31
11 Future Outlook 33
12 Appendix 34
12.1 Methodology 34
12.1.1 Coverage 35
12.1.2 Secondary Research 35
12.1.3 Primary Research 36
12.1.4 Models 36
12.1.5 Forecasts 37
12.1.6 Expert Panels 37
12.2 Contact US 37
12.3 Disclaimer 37